Congress Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-108,288
Closed -$442K 361
2020
Q3
$442K Hold
108,288
﹤0.01% 299
2020
Q2
$366K Buy
108,288
+3,620
+3% +$10.5K ﹤0.01% 292
2020
Q1
$244K Hold
104,668
﹤0.01% 312
2019
Q4
$381K Sell
104,668
-29,065
-22% -$235K ﹤0.01% 319
2019
Q3
$1.11M Sell
133,733
-13,465
-9% -$109K 0.01% 284
2019
Q2
$1.27M Hold
147,198
0.02% 287
2019
Q1
$1.57M Sell
147,198
-2,555
-2% -$27.4K 0.02% 277
2018
Q4
$1.31M Buy
149,753
+6,275
+4% +$79.9K 0.02% 294
2018
Q3
$2.41M Buy
143,478
+56,880
+66% +$1.23M 0.03% 265
2018
Q2
$1.81M Buy
86,598
+46,770
+117% +$866K 0.03% 274
2018
Q1
$641K Buy
+39,828
New +$789K 0.01% 333

Other funds holding SPPI

Congress Asset Management's SPPI Position: Q4 2020 in Review

Congress Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2020, closing a stake of 108,288 shares — an estimated $442K sold.

Congress Asset Management first reported a position in SPPI in Q1 2018 and held it in 11 quarters. The position peaked at $2.41M in Q3 2018. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Congress Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Congress Asset Management sold 108,288 Spectrum Pharmaceuticals Inc shares in Q4 2020, an estimated $442K.
  • Congress Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2018 and held it in 11 quarters.
  • Congress Asset Management's Spectrum Pharmaceuticals Inc position peaked at $2.41M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Congress Asset Management's 13F filing for Q4 2020, filed 26 Jan 2021.